Literature DB >> 6727874

Lack of retrovirus gene expression in somatic cell hybrids of friend cells and teratocarcinoma cells with a teratocarcinoma phenotype.

W Asche, G Colletta, G Warnecke, P Nobis, S Pennie, R M King, W Ostertag.   

Abstract

Two types of hybrids between cells with erythroid phenotype (Friend cells) and teratocarcinoma cells can be distinguished: cell hybrids with an erythroid phenotype, which release or can be induced to release large amounts of Friend spleen focus-forming virus (F-SFFV) on exposure to bromodeoxyuridine and cell hybrids with a teratocarcinoma phenotype, which do not release Friend virus and are not inducible for F-SFFV release. In this paper, we attempted to relate these differences to the expression of F-SFFV and Friend murine leukemia virus (F-MuLV) functions. Teratocarcinoma phenotype hybrids retained F-SFFV-and F-MuLV-related provirus sequences. They did not express F-SFFV- or F-MuLV-related RNA or proteins. The hybrids differentiated to endoderm-like cells on exposure to retinoic acid or hexamethylene-bis -acetamide. These cells, in contrast to the teratocarcinoma phenotype (uninduced) cells expressing SSEA-1-like antigens, did not express SSEA-1-like antigens; they formed typical, prekeratin-staining cytoskeletal structures and could be induced to release mouse interferon. The differentiating cells, but not the uninduced teratocarcinoma hybrids, were infected productively with F-MuLV or the F-MuLV--F-SFFV complex. They, however, did not express endogenous F-SFFV. Endogenous F-SFFV functions could not be rescued by infection with F-MuLV. Induction of teratocarcinoma hybrids with retinoic acid did not activate endogenous F-MuLV or F-SFFV transcription or protein synthesis. These data demonstrated two control mechanisms of Friend virus repression: one which acted trans during formation of the cell hybrids and was maintained only in teratocarcinoma phenotype cells and the other which acted cis and was still operative during induction of endodermal differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6727874      PMCID: PMC368841          DOI: 10.1128/mcb.4.5.923-930.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.

Authors:  J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

2.  Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.

Authors:  D E Swartzendruber; J M Lehman
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

3.  Virus infection of murine teratocarcinoma stem cell lines.

Authors:  N M Teich; R A Weiss; G R Martin; D R Lowy
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

4.  Susceptibility of teratocarcinoma cells to adenovirus type 2.

Authors:  F Kelly; M Boccara
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

5.  [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].

Authors:  H Jakob; T Boon; J Gaillard; J Nicolas; F Jacob
Journal:  Ann Microbiol (Paris)       Date:  1973-10

6.  Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma.

Authors:  J M Lehman; W C Speers; D E Swartzendruber; G B Pierce
Journal:  J Cell Physiol       Date:  1974-08       Impact factor: 6.384

7.  Hemoglobin synthesis in cell hybrids formed between teratocarcinoma and Friend erythroleukemia cells.

Authors:  M W McBurney
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

8.  Appearance of interferon inducibility and sensitivity during differentiation of murine teratocarcinoma cells in vitro.

Authors:  D C Burke; C F Graham; J M Lehman
Journal:  Cell       Date:  1978-02       Impact factor: 41.582

9.  Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virus.

Authors:  W Ostertag; G Roesler; C J Krieg; J Kind; T Cole; T Crozier; G Gaedicke; G Steinheider; N Kluge; S Dube
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Viral protein synthesis in Friend erythroleukemia cell lines.

Authors:  J Racevskis; G Koch
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  6 in total

1.  Retroviral expression in embryonic stem cells and hematopoietic stem cells.

Authors:  S R Cherry; D Biniszkiewicz; L van Parijs; D Baltimore; R Jaenisch
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation.

Authors:  C Laker; J Meyer; A Schopen; J Friel; C Heberlein; W Ostertag; C Stocking
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

3.  Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells.

Authors:  H Weiher; E Barklis; W Ostertag; R Jaenisch
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

4.  Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene.

Authors:  B Seliger; R Kollek; C Stocking; T Franz; W Ostertag
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

5.  Retroviral mutants efficiently expressed in embryonal carcinoma cells.

Authors:  T Franz; F Hilberg; B Seliger; C Stocking; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

Authors:  C Baum; S Hegewisch-Becker; H G Eckert; C Stocking; W Ostertag
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.